34 filings
Page 2 of 2
8-K
rb2 glon3r
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
cwimtms qpkg8z
20 Sep 22
Departure of Directors or Certain Officers
5:14pm
8-K
h6inqe
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
8-K
oynmt
14 Jul 22
Departure of Directors or Certain Officers
5:13pm
8-K
q4mv179
10 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
bhhpmujnx3bhfm0wlz2o
11 May 22
Absci Reports First Quarter 2022 Financial and Operating Results
8:15am
8-K
84q tx8ct9bv7vdnwa
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
zt6xwo1 yzu
21 Mar 22
Departure of Directors or Certain Officers
4:20pm
8-K
0x0ce29
10 Jan 22
Departure of Directors or Certain Officers
8:58am
8-K
bij2nxwv3 qveozkb
7 Jan 22
Absci Announces Research Collaboration with Merck
8:53am
8-K
65jno85
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am
8-K
p47ib3ag92t9lml 5joc
7 Sep 21
Absci Reports Second Quarter 2021 Financial and Operating Results
8:40am
8-K
70jvyix
24 Aug 21
Departure of Directors or Certain Officers
9:03am
8-K
p3q0qgytuufgk
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm